Entrada Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
May 1 04:23
Entrada Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Apr 30 04:15
Entrada Therapeutics | ARS: Annual Report to Security Holders
Apr 29 21:18
Entrada Therapeutics | DEFA14A: Others
Apr 29 21:18
Entrada Therapeutics | DEF 14A: Definitive information statements
Apr 29 21:13
Entrada Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Apr 27 04:19
Entrada Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Apr 26 04:38
Entrada Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Apr 25 04:25
Entrada Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Apr 24 04:23
Entrada Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Apr 20 04:16
Entrada Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Apr 19 19:03
Entrada Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Apr 19 04:22
Entrada Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Apr 18 04:21
Entrada Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Apr 17 04:22
Entrada Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Apr 16 04:20
Entrada Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Apr 13 04:10
Entrada Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Apr 12 04:26
Entrada Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director KIM PETER S
Apr 11 04:39
Entrada Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Apr 11 04:18
Entrada Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144
Apr 10 04:17
No Data
No Data